Cardiac safety of afatinib: a review of data from clinical trials

por Ewer, Michael S., Patel, Kalpesh, O’Brien, Dennis, Lorence, Robert M.
Publicado 2015

Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC

por Westeel, Virginie, Schuette, Wolfgang, Urban, Thierry, Radonjic, Dejan, von Wangenheim, Ute, Lorence, Robert M., Reck, Martin
Publicado 2023

Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, includi...

por Chang, Gee-Chen, Lam, David Chi-Leung, Tsai, Chun-Ming, Chen, Yuh-Min, Shih, Jin-Yuan, Aggarwal, Shyam, Wang, Shuhang, Kim, Sang-We, Kim, Young-Chul, Wahid, Ibrahim, Li, Rubi, Lim, Darren Wan-Teck, Sriuranpong, Virote, Chan, Raymond Tsz-Tong, Lorence, Robert M., Carriere, Philippe, Raabe, Christina, Cseh, Agnieszka, Park, Keunchil
Publicado 2021